ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways

in Endocrine-Related Cancer
View More View Less
  • 1 Department of Neurosurgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, China
  • | 2 School of Medicine, Southeast University, Nanjing, Jiangsu Province, China

Correspondence should be addressed to C Ma: machiyuan_nju@126.com

*(J Zhu and C Tang contributed equally to this work)

Restricted access

Dopamine agonist (DA) is the first choice for the treatment of prolactinomas, and drug resistance is unavoidable during treatment due to the heterogeneity of tumors. The two prolactinoma cell lines (GH3 cells and MMQ cells) were found to have different sensitivity and responding modes to the cabergoline (CAB) and bromocriptine (BRC). In this research, we disclosed the capability of ACT001, a derivative of parthenolide analogs, to activate AMPK by increasing the intracellular reactive oxygen species (ROS) level and AMP/ATP ratio to reverse DA resistance through dual pathways in prolactinoma cells. The results indicated that ACT001 could reverse the CAB resistance in GH3 cells by inhibiting the mTOR signaling pathway, inducing cell death through autophagy, and reverse the BRC resistance in MMQ cells by activating the EGR1 signaling pathway, inducing cell death through apoptosis. Our results suggested that ACT001 is a promising therapeutic compound for treating DA-resistant prolactinomas.

 

Society for Endocrinology logo

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 668 668 487
Full Text Views 31 31 22
PDF Downloads 35 35 24
  • Albert V & Hall MN 2015 MTOR signaling in cellular and organismal energetics. Current Opinion in Cell Biology 33 5566. (https://doi.org/10.1016/j.ceb.2014.12.001)

    • Search Google Scholar
    • Export Citation
  • An Y, Guo W, Li L, Xu C, Yang D, Wang S, Lu Y, Zhang Q, Zhai J & Fan H et al.2015 Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo. PLoS ONE 10 e0116202. (https://doi.org/10.1371/journal.pone.0116202)

    • Search Google Scholar
    • Export Citation
  • Caccavelli L, Morange-Ramos I, Kordon C, Jaquet P & Enjalbert A 1996 Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas. Journal of Neuroendocrinology 8 737746. (https://doi.org/10.1046/j.1365-2826.1996.04902.x)

    • Search Google Scholar
    • Export Citation
  • Cai L, Leng ZG, Guo YH, Lin SJ, Wu ZR, Su ZP, Lu JL, Wei LF, Zhuge QC & Jin K et al.2016 Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine 52 641651. (https://doi.org/10.1007/s12020-015-0824-2)

    • Search Google Scholar
    • Export Citation
  • D’Anneo A, Carlisi D, Lauricella M, Emanuele S, Di Fiore R, Vento R & Tesoriere G 2013 Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells. Journal of Cellular Physiology 228 952967. (https://doi.org/10.1002/jcp.24131)

    • Search Google Scholar
    • Export Citation
  • Di Biase S, Shim HS, Kim KH, Vinciguerra M, Rappa F, Wei M, Brandhorst S, Cappello F, Mirzaei H & Lee C et al.2017 Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. PLoS Biology 15 e2001951. (https://doi.org/10.1371/journal.pbio.2001951)

    • Search Google Scholar
    • Export Citation
  • Dong Q, Zhang J, Hendricks DT & Zhao X 2011 GRObeta and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells. Oncology Reports 25 10311037. (https://doi.org/10.3892/or.2011.1163)

    • Search Google Scholar
    • Export Citation
  • Filomeni G, De Zio D & Cecconi F 2015 Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death and Differentiation 22 377388. (https://doi.org/10.1038/cdd.2014.150)

    • Search Google Scholar
    • Export Citation
  • Gorvin CM, Newey PJ, Rogers A, Stokes V, Neville MJ, Lines KE, Ntali G, Lees P, Morrison PJ & Singhellakis PN et al.2019 Association of prolactin receptor (PRLR) variants with prolactinomas. Human Molecular Genetics 28 10231037. (https://doi.org/10.1093/hmg/ddy396)

    • Search Google Scholar
    • Export Citation
  • Ham J, Eilers A, Whitfield J, Neame SJ & Shah B 2000 C-Jun and the transcriptional control of neuronal apoptosis. Biochemical Pharmacology 60 10151021. (https://doi.org/10.1016/s0006-2952(0000372-5)

    • Search Google Scholar
    • Export Citation
  • Hart PC, Mao M, De Abreu AL, Ansenberger-Fricano K, Ekoue DN, Ganini D, Kajdacsy-Balla A, Diamond AM, Minshall RD & Consolaro ME et al.2015 MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nature Communications 6 6053. (https://doi.org/10.1038/ncomms7053)

    • Search Google Scholar
    • Export Citation
  • Jin P, Madieh S & Augsburger LL 2007 The solution and solid state stability and excipient compatibility of parthenolide in feverfew. AAPS PharmSciTech 8 E105. (https://doi.org/10.1208/pt0804105)

    • Search Google Scholar
    • Export Citation
  • Lesiak K, Koprowska K, Zalesna I, Nejc D, Duchler M & Czyz M 2010 Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro. Melanoma Research 20 2134. (https://doi.org/10.1097/CMR.0b013e328333bbe4)

    • Search Google Scholar
    • Export Citation
  • Li ZL, Liang S, Wang ZC, Li YB, Guo CX, Fang F, Gong SL & Lin CH 2014 Expression of Smac induced by the Egr1 promoter enhances the radiosensitivity of breast cancer cells. Cancer Gene Therapy 21 142149. (https://doi.org/10.1038/cgt.2014.9)

    • Search Google Scholar
    • Export Citation
  • Li Q, Sun Y, Liu B, Li J, Hao X, Ge W, Zhang X, Bao S, Gong J & Jiang Z et al.2020 ACT001 modulates the NF-kappaB/MnSOD/ROS axis by targeting IKKbeta to inhibit glioblastoma cell growth. Journal of Molecular Medicine 98 263277. (https://doi.org/10.1007/s00109-019-01839-0)

    • Search Google Scholar
    • Export Citation
  • Lickliter JD, Jennens R, Lemech CR, Kichenadasse G, Cai D & Su SY-C 2021 Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors. Journal of Clinical Oncology 39 20372037. (https://doi.org/10.1200/JCO.2021.39.15_suppl.2037)

    • Search Google Scholar
    • Export Citation
  • Lin SC & Hardie DG 2018 AMPK: sensing glucose as well as cellular energy status. Cell Metabolism 27 299313. (https://doi.org/10.1016/j.cmet.2017.10.009)

    • Search Google Scholar
    • Export Citation
  • Maiter D 2019 Management of dopamine agonist-resistant prolactinoma. Neuroendocrinology 109 4250. (https://doi.org/10.1159/000495775)

  • Melmed S 2020 Pituitary-tumor endocrinopathies. New England Journal of Medicine 382 937950. (https://doi.org/10.1056/NEJMra1810772)

  • Molitch ME 2014 Management of medically refractory prolactinoma. Journal of Neuro-Oncology 117 421428. (https://doi.org/10.1007/s11060-013-1270-8)

    • Search Google Scholar
    • Export Citation
  • Monsalves E, Juraschka K, Tateno T, Agnihotri S, Asa SL, Ezzat S & Zadeh G 2014 The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas. Endocrine-Related Cancer 21 R331R344. (https://doi.org/10.1530/ERC-14-0188)

    • Search Google Scholar
    • Export Citation
  • Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP & Rangnekar VM 1997 Early growth response-1-dependent apoptosis is mediated by p53. Journal of Biological Chemistry 272 2013120138. (https://doi.org/10.1074/jbc.272.32.20131)

    • Search Google Scholar
    • Export Citation
  • Oakhill JS, Scott JW & Kemp BE 2012 AMPK functions as an adenylate charge-regulated protein kinase. Trends in Endocrinology and Metabolism 23 125132. (https://doi.org/10.1016/j.tem.2011.12.006)

    • Search Google Scholar
    • Export Citation
  • Panieri E & Santoro MM 2016 ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death and Disease 7 e2253. (https://doi.org/10.1038/cddis.2016.105)

    • Search Google Scholar
    • Export Citation
  • Peverelli E, Mantovani G, Vitali E, Elli FM, Olgiati L, Ferrero S, Laws ER, Della Mina P, Villa A & Beck-Peccoz P et al.2012 Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs. Journal of Clinical Endocrinology and Metabolism 97 967977. (https://doi.org/10.1210/jc.2011-2902)

    • Search Google Scholar
    • Export Citation
  • Primeau V, Raftopoulos C & Maiter D 2012 Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. European Journal of Endocrinology 166 779786. (https://doi.org/10.1530/EJE-11-1000)

    • Search Google Scholar
    • Export Citation
  • Rabinovitch RC, Samborska B, Faubert B, Ma EH, Gravel SP, Andrzejewski S, Raissi TC, Pause A, St-Pierre J & Jones RG 2017 AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Reports 21 19. (https://doi.org/10.1016/j.celrep.2017.09.026)

    • Search Google Scholar
    • Export Citation
  • Shimazu S, Shimatsu A, Yamada S, Inoshita N, Nagamura Y, Usui T & Tsukada T 2012 Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levels. European Journal of Endocrinology 166 383390. (https://doi.org/10.1530/EJE-11-0656)

    • Search Google Scholar
    • Export Citation
  • Shimobayashi M & Hall MN 2014 Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nature Reviews: Molecular Cell Biology 15 155162. (https://doi.org/10.1038/nrm3757)

    • Search Google Scholar
    • Export Citation
  • Steinberg GR & Carling D 2019 AMP-activated protein kinase: the current landscape for drug development. Nature Reviews: Drug Discovery 18 527551. (https://doi.org/10.1038/s41573-019-0019-2)

    • Search Google Scholar
    • Export Citation
  • Tang C, Sun R, Wen G, Zhong C, Yang J, Zhu J, Cong Z, Luo X & Ma C 2019 Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively. Cell Death and Disease 10 335. (https://doi.org/10.1038/s41419-019-1526-0)

    • Search Google Scholar
    • Export Citation
  • Thiel G & Cibelli G 2002 Regulation of life and death by the zinc finger transcription factor Egr-1. Journal of Cellular Physiology 193 287292. (https://doi.org/10.1002/jcp.10178)

    • Search Google Scholar
    • Export Citation
  • Vroonen L, Daly AF & Beckers A 2019 Epidemiology and management challenges in prolactinomas. Neuroendocrinology 109 2027. (https://doi.org/10.1159/000497746)

    • Search Google Scholar
    • Export Citation
  • Wen G, Tang C, Zhong C, Li X, Li J, Li L, Yang Y & Ma C 2016 Mononostril versus binostril endoscopic transsphenoidal approach for pituitary adenomas: a systematic review and meta-analysis. PLoS ONE 11 e0153397. (https://doi.org/10.1371/journal.pone.0153397)

    • Search Google Scholar
    • Export Citation
  • Xi XN, Liu N, Wang QQ, Wu HT, He HB, Wang LL, Zhang TJ, Sun L, Yin Z & Chen Y et al.2019 Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001. Journal of Chromatography: B, Analytical Technologies in the Biomedical and Life Sciences 1104 2939. (https://doi.org/10.1016/j.jchromb.2018.11.004)

    • Search Google Scholar
    • Export Citation
  • Xu Y, Fang F, Miriyala S, Crooks PA, Oberley TD, Chaiswing L, Noel T, Holley AK, Zhao Y & Kiningham KK et al.2013 KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells. Cancer Research 73 44064417. (https://doi.org/10.1158/0008-5472.CAN-12-4297)

    • Search Google Scholar
    • Export Citation
  • Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J & Tong Z et al.2012 Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. Journal of Medicinal Chemistry 55 87578769. (https://doi.org/10.1021/jm301064b)

    • Search Google Scholar
    • Export Citation
  • Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, Zhang S, Huang Q & Shi M 2017 ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Molecular Cancer 16 79. (https://doi.org/10.1186/s12943-017-0648-1)

    • Search Google Scholar
    • Export Citation
  • Zhu J, Feng K, Tang C, Yang J, Cai X, Zhong C & Ma C 2021 Olfactory outcomes after endonasal skull base surgery: a systematic review. Neurosurgical Review 44 18051814. (https://doi.org/10.1007/s10143-020-01385-1)

    • Search Google Scholar
    • Export Citation